A randomised placebo-controlled multicentre trial of intravenous semapimod HCl for moderate to severe Crohn's disease
暂无分享，去创建一个
P. Rutgeerts | D. Hommes | A. Buchman | A. Kornbluth | C. J. van der Woude | I. Dotan | R. Eliakim | D. Rachmilewitz | U. Seidler | B. Bokemeyer | U. Mahadevan | E. Goldin | B. Powers | T. Plasse | C. Maaser | S. Schreiber | S. Bar-Meir | Jörg C Hoffman | Douglas Homoky